Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-03-15
2011-03-15
Olson, Eric S (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S123120
Reexamination Certificate
active
07906492
ABSTRACT:
A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal, and at least one antibody for the cancer. A method of treating cancer in a mammal is also disclosed. The method comprises administering a suitable orally administered glucan and at least one antibody for the treatment of cancer to the mammal. In addition a composition for delivery of peptide, protein, RNA, DNA or plasmid comprising effective amount of a beta-glucan is disclosed.
REFERENCES:
patent: 3975553 (1976-08-01), Griffon
patent: 3987166 (1976-10-01), Komatsu et al.
patent: 4251519 (1981-02-01), Robbins et al.
patent: 4343784 (1982-08-01), Massot et al.
patent: 4454289 (1984-06-01), Nakajima et al.
patent: 4705780 (1987-11-01), Massot et al.
patent: 4761402 (1988-08-01), Williams et al.
patent: 4810646 (1989-03-01), Jamas et al.
patent: 4818752 (1989-04-01), Williams et al.
patent: 4833131 (1989-05-01), Williams et al.
patent: 4900722 (1990-02-01), Williams et al.
patent: 4926094 (1990-05-01), Bondeson et al.
patent: 4992540 (1991-02-01), Jamas et al.
patent: 5032401 (1991-07-01), Jamas et al.
patent: 5037972 (1991-08-01), Jamas et al.
patent: 5130127 (1992-07-01), Herlyn
patent: 5189028 (1993-02-01), Nikl et al.
patent: 5223491 (1993-06-01), Donzis
patent: 5250436 (1993-10-01), Jamas et al.
patent: 5504079 (1996-04-01), Jamas et al.
patent: 5519009 (1996-05-01), Donzis
patent: 5532223 (1996-07-01), Jamas et al.
patent: 5576015 (1996-11-01), Donzis
patent: 5607677 (1997-03-01), Jamas et al.
patent: 5614242 (1997-03-01), Fox
patent: 5622939 (1997-04-01), Jamas et al.
patent: 5622940 (1997-04-01), Ostroff
patent: 5696079 (1997-12-01), Lane et al.
patent: 5702719 (1997-12-01), Donzis
patent: 5726023 (1998-03-01), Cheever et al.
patent: 5741495 (1998-04-01), Jamas et al.
patent: 5783569 (1998-07-01), Jamas et al.
patent: 5801236 (1998-09-01), Kamb
patent: 5804199 (1998-09-01), Aasjord et al.
patent: 5811542 (1998-09-01), Jamas et al.
patent: 5817643 (1998-10-01), Jamas et al.
patent: 5849720 (1998-12-01), Jamas et al.
patent: 5980918 (1999-11-01), Klein
patent: 6020324 (2000-02-01), Jamas et al.
patent: 6117850 (2000-09-01), Patchen et al.
patent: 6143731 (2000-11-01), Jamas et al.
patent: 6143883 (2000-11-01), Lehmann et al.
patent: 6180614 (2001-01-01), Davis
patent: 6369216 (2002-04-01), Patchen et al.
patent: 6573245 (2003-06-01), Marciani
patent: 6664370 (2003-12-01), Cheever et al.
patent: 7011845 (2006-03-01), Kozbor et al.
patent: 7030101 (2006-04-01), Pavliak et al.
patent: 7070778 (2006-07-01), Yvin et al.
patent: 2002/0044919 (2002-04-01), Yu
patent: 2002/0119928 (2002-08-01), McAnalley
patent: 2003/0180254 (2003-09-01), Lane et al.
patent: 2004/0109857 (2004-06-01), Chu et al.
patent: 2004/0116379 (2004-06-01), Cheung
patent: 2004/0248772 (2004-12-01), Yagita
patent: 2004/0266726 (2004-12-01), Yagita
patent: 2005/0118187 (2005-06-01), Yu
patent: 2005/0208079 (2005-09-01), Cassone et al.
patent: 2006/0009419 (2006-01-01), Ross et al.
patent: 2006/0020128 (2006-01-01), Cheung
patent: 2006/0165700 (2006-07-01), Ostroff et al.
patent: 2006/0188506 (2006-08-01), Cheung
patent: 2006/0263355 (2006-11-01), Quan et al.
patent: 2007/0020232 (2007-01-01), Rossignol et al.
patent: 2007/0059310 (2007-03-01), Karel
patent: 2007/0134259 (2007-06-01), Bundle et al.
patent: 30 19 614 (1981-12-01), None
patent: 0463540 (1992-02-01), None
patent: 0759089 (1997-02-01), None
patent: WO 91/03248 (1991-03-01), None
patent: WO 99/52548 (1999-10-01), None
patent: WO 01/68105 (2001-11-01), None
patent: WO 01/80807 (2001-11-01), None
patent: WO 02/058711 (2002-08-01), None
patent: WO 03/004507 (2003-01-01), None
patent: WO 03/054077 (2003-07-01), None
patent: WO 2004/30613 (2004-03-01), None
patent: WO 2005/027936 (2005-03-01), None
patent: WO 2005/027938 (2005-03-01), None
patent: WO 2005/049044 (2005-06-01), None
patent: WO 2005/070213 (2005-08-01), None
patent: WO 2005/113128 (2005-12-01), None
patent: WO 2006/007372 (2006-01-01), None
patent: WO 2006/032039 (2006-03-01), None
patent: WO 2006/085895 (2006-08-01), None
patent: WO 2006/119395 (2006-11-01), None
patent: WO 2007/050643 (2007-05-01), None
patent: WO 2007/063267 (2007-06-01), None
patent: WO 2007/063268 (2007-06-01), None
patent: WO 2007/084661 (2007-08-01), None
patent: WO 2007/109564 (2007-09-01), None
Robertsen et al., “Beta glucans as Immunostimulatns in Fish” Modulators of Fish Immune Response (1994) vol. 1, pp. 83-99.
Groβhans, “Gene therapy—when a simple concept meets a complex reality” Funct Integr Genomics (2000) vol. 1 pp. 142-145.
Bohm et al., “Rheological studies of barley (1.3)(1.4)-b-glucan in concentrated solution: mechanistic and kinetic investigation of the gel formation” Carbohydrate research (1999) vol. 315, pp. 302-311.
Czop et al., “Properties of Glycans That Activate the Human Alternative Complement Pathway and Interact With the Human Monocyte B-Glucan Receptor” The Journal of Immunology (1985) vol. 135, No. 5, pp. 3388-3393.
Wilson et al., “Reduced and High Molecular Weight Barley beta-Glucans Decrease Plasma Total and Non-HDL-Cholesterol in Hypercholesterolemic Syrian Golden Hamsters” Journal of Nutrition (2004) vol. 134, pp. 2617-2622.
European Patent Publication No. EP 0194851 A2 for the Wistar Institute et al., Sep. 17, 1986 for “Human tumor therapy”.
Japanese Patent Publication No. JP 62252730 A2 for Takeda Chem. Ind. Ltd. et al., Nov. 4, 1987 for “Antitumor Agent”.
Japanese Patent Publication No. JP 63307825 A2 for Nippo Beet Sugar Mfg Co. Ltd. et al., Dec. 15, 1988 for “Antitumor Agent and Production Thereof”.
International Patent Publication No. WO 2004/014320 A2 for Biopolymer engineering, Inc. et al., Feb. 19, 2004 for “Methods of using beta glucan as a radioprotective agent”.
International Patent Publication No. WO 2004/14320 A3 for Biopolymer engineering, Inc. et al., Feb. 19, 2004 for “Methods of using beta glucan as a radioprotective”, Published with Sep. 2, 2004 International Search Report.
International Patent Publication No. WO 2004/021994 A2 for Biopolymer engineering, Inc. et al., Mar. 18, 2004 for “Cancer therapy using whole glucan petioles and antibodies”.
International International Patent Publication No. WO 2004/21994 A3 for Biopolymer engineering, Inc. et al., Mar. 18, 2004 for “Cancer therapy using whole glucan particles and antibodies”, Published with Aug. 12, 2004 International Search Report.
International Patent Publication No. WO 00/15238 for Nabi et al., Mar. 23, 2000 for “Composition of β-glucans and specific IGIV”, Published with Aug. 31, 2000 International Search Report.
International Patent Publication No. WO 01/62283 A2 for Biotech Asa et al., Aug. 30, 2001 for “Novel, Non-antigenic, Muscosal Adjuvant Formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces”.
International Patent Application Publication No. WO 98/39013 for Peregrine Pharmaceutical, Inc. et al., Sep. 11, 1998 for “Composition and Method for Treating Cancer and Immunological Disorders Resulting in Chronic Conditions”.
PCT International Preliminary Examination Report for Sloan-Kettering Institute for Cancer Research, Int'l Application No. PCT/US02/01276, Filed Jan. 15, 2002, Dated Mar. 27, 2003.
PCT International Search Report for Sloan-Kettering Institute for Cancer Research, Int'l Application No. PCT/US04/23099, Filed Jul. 16, 2004, Dated Feb. 28, 2005.
PCT International Search Report for Sloan-Kettering Institute for Cancer Research, Int'l Application No. PCT/US04/23099, Filed Jul. 16, 2004, Dated Apr. 14, 2005.
PCT Written Opinion of the International Searching Authority for Sloan-Kettering Institute for Cancer Research, Int'l Application No. PCT/US04/23099, Fi
Law Offices of Albert Wai-Kit Chan PLLC
Olson Eric S
Sloan-Kettering Institute for Cancer Research
LandOfFree
Therapy-enhancing glucan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapy-enhancing glucan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy-enhancing glucan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2739820